Patents by Inventor Balamurali Ambati

Balamurali Ambati has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180141995
    Abstract: The present invention provides an intraceptor that interacts with and decreases activity of with VEGF and/or a VEGFR for the treatment of angiogenesis-related conditions. The present invention further provides pharmaceutical compositions, and methods of use thereof for the treatment and prevention of an angiogenesis-related condition using said intraceptors. The invention further provides for nucleic acids encoding said intraceptors.
    Type: Application
    Filed: September 19, 2016
    Publication date: May 24, 2018
    Applicants: Medical College of Georgia Research Institute, University of Utah Research Foundation
    Inventors: Balamurali Ambati, Nirbhai Singh, Shivan Amin
  • Publication number: 20160331588
    Abstract: An ocular stent device (100) can include an elongate arcuate body portion (102) configured in size and shape to be inserted into the Schlemm's canal. The body portion (102) can be inserted along an arc of at least 100 degrees of the Schlemm's canal. The body portion (102) can include a plurality of through-holes (104) adapted to direct flow of aqueous humor from a trabecular meshwork to episcleral collector channels of the eye.
    Type: Application
    Filed: January 14, 2015
    Publication date: November 17, 2016
    Inventors: Balamurali Ambati, Alan Crandall, Bruce K. Gale, Christopher Lambert
  • Patent number: 9447166
    Abstract: The present invention provides an intraceptor that interacts with and decreases activity of with VEGF and/or a VEGFR for the treatment of angiogenesis-related conditions. The present invention further provides pharmaceutical compositions, and methods of use thereof, for the treatment and prevention of an angiogenesis-related condition using said intraceptors. The invention further provides for nucleic acids encoding said intraceptors.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: September 20, 2016
    Assignees: Medical College of Georgia Research Institute, University of Utah Research Foundation
    Inventors: Balamurali Ambati, Nirbhai Singh, Shivan Amin
  • Publication number: 20140329888
    Abstract: The present invention provides an intraceptor that interacts with and decreases activity of with VEGF and/or a VEGFR for the treatment of angiogenesis-related conditions. The present invention further provides pharmaceutical compositions, and methods of use thereof, for the treatment and prevention of an angiogenesis-related condition using said intraceptors. The invention further provides for nucleic acids encoding said intraceptors.
    Type: Application
    Filed: March 31, 2014
    Publication date: November 6, 2014
    Inventors: Balamurali Ambati, Nirbhai Singh, Shivan Amin
  • Publication number: 20130130980
    Abstract: The present invention provides an intraceptor that interacts with and decreases activity of with VEGF and/or a VEGFR for the treatment of angiogenesis-related conditions. The present invention further provides pharmaceutical compositions, and methods of use thereof, for the treatment and prevention of an angiogenesis-related condition using said intraceptors. The invention further provides for nucleic acids encoding said intraceptors.
    Type: Application
    Filed: July 2, 2012
    Publication date: May 23, 2013
    Inventors: Balamurali Ambati, Nirbhai Singh, Shivan Amin
  • Patent number: 8211864
    Abstract: The present invention provides an intraceptor that interacts with and decreases activity of with VEGF and/or a VEGFR for the treatment of angiogenesis-related conditions. The present invention further provides pharmaceutical compositions, and methods of use thereof, for the treatment and prevention of an angiogenesis-related condition using said intraceptors. The invention further provides for nucleic acids encoding said intraceptors.
    Type: Grant
    Filed: January 26, 2006
    Date of Patent: July 3, 2012
    Assignees: Medical College of Georgia Research Institute, University of Utah Research Foundation
    Inventors: Balamurali Ambati, Nirbhai Singh, Shivan Amin
  • Publication number: 20080318857
    Abstract: The present invention provides an intraceptor that interacts with and decreases activity of with VEGF and/or a VEGFR for the treatment of angiogenesis-related conditions. The present invention further provides pharmaceutical compositions, and methods of use thereof, for the treatment and prevention of an angiogenesis-related condition using said intraceptors. The invention further provides for nucleic acids encoding said intraceptors.
    Type: Application
    Filed: January 26, 2006
    Publication date: December 25, 2008
    Inventors: Balamurali Ambati, Nirbhai Singh, Shivan Amin